From With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells:

Cell Engineering
Cell Engineering

Sigilon Therapeutics uses a capsule it developed to safely deliver engineered cells, which can deliver targeted protein therapeutics. Image courtesy of Sigilon.